S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Medical Transcription Billing Stock Price, News & Analysis (NASDAQ:MTBC)

$3.90
-0.20 (-4.88 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$3.90
Now: $3.90
$4.13
50-Day Range
$3.78
MA: $4.15
$4.53
52-Week Range
$3.25
Now: $3.90
$5.65
Volume14,466 shs
Average Volume49,635 shs
Market Capitalization$46.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. Read More…

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTBC
CUSIPN/A
Phone732-873-5133

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$50.55 million
Cash Flow$0.06 per share
Book Value$3.29 per share

Profitability

Net Income$-2,140,000.00

Miscellaneous

Employees2,400
Market Cap$46.93 million
Next Earnings Date11/6/2019 (Confirmed)
OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.


Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions

What is Medical Transcription Billing's stock symbol?

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

How were Medical Transcription Billing's earnings last quarter?

Medical Transcription Billing Corp (NASDAQ:MTBC) posted its quarterly earnings data on Wednesday, August, 7th. The technology company reported ($0.19) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.19). The technology company earned $16.75 million during the quarter, compared to the consensus estimate of $15.33 million. Medical Transcription Billing had a negative net margin of 9.21% and a negative return on equity of 17.50%. View Medical Transcription Billing's Earnings History.

When is Medical Transcription Billing's next earnings date?

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Medical Transcription Billing.

How can I listen to Medical Transcription Billing's earnings call?

Medical Transcription Billing will be holding an earnings conference call on Wednesday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Medical Transcription Billing issued on next quarter's earnings?

Medical Transcription Billing updated its FY 2019 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.677 million, compared to the consensus revenue estimate of $64.4 million.

What price target have analysts set for MTBC?

3 Wall Street analysts have issued 1-year price targets for Medical Transcription Billing's shares. Their predictions range from $6.00 to $6.00. On average, they anticipate Medical Transcription Billing's share price to reach $6.00 in the next year. This suggests a possible upside of 53.8% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing.

What is the consensus analysts' recommendation for Medical Transcription Billing?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Has Medical Transcription Billing been receiving favorable news coverage?

Media coverage about MTBC stock has been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a coverage optimism score of -2.0 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Medical Transcription Billing.

Are investors shorting Medical Transcription Billing?

Medical Transcription Billing saw a decline in short interest in September. As of September 30th, there was short interest totalling 109,200 shares, a decline of 36.6% from the August 30th total of 172,300 shares. Based on an average daily volume of 28,700 shares, the days-to-cover ratio is presently 3.8 days. Approximately 1.8% of the shares of the company are sold short. View Medical Transcription Billing's Current Options Chain.

Who are some of Medical Transcription Billing's key competitors?

What other stocks do shareholders of Medical Transcription Billing own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Sophiris Bio (SPHS), Verastem (VSTM), Microbot Medical (MBOT), Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Etsy (ETSY) and Interpace Diagnostics Group (IDXG).

How do I buy shares of Medical Transcription Billing?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medical Transcription Billing's stock price today?

One share of MTBC stock can currently be purchased for approximately $3.90.

How big of a company is Medical Transcription Billing?

Medical Transcription Billing has a market capitalization of $46.93 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

What is Medical Transcription Billing's official website?

The official website for Medical Transcription Billing is http://www.mtbc.com/.

How can I contact Medical Transcription Billing?

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.


MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  199 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  405
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: No Load Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel